Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ILG
2476
DELISTED
ILG, Inc Common Stock
ILG
| $1.52M | ﹤0.01% |
55,381
+16,506
| +42% | +$418K |
|
|
TDAY
2477
USA Today Co
TDAY
$1.17B
| $1.52M | ﹤0.01% |
112,741
+101,957
| +945% | +$1.36M |
|
|
SIOX
2478
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.52M | ﹤0.01% |
8,188
+1,938
| +31% | +$340K |
|
2479
DexCom
DXCM
$31.3B
| $1.51M | ﹤0.01% |
82,856
+32,104
| +63% | +$593K |
|
|
SPN
2480
DELISTED
Superior Energy Services, Inc.
SPN
| $1.51M | ﹤0.01% |
14,538
+7,814
| +116% | +$909K |
|
2481
CALL
Opko Health
OPK
$985M
| $1.51M | ﹤0.01% |
230,100
+174,800
| +316% | +$1.23M |
|
2482
CALL
Workday
WDAY
$42B
| $1.51M | ﹤0.01% |
15,600
+12,500
| +403% | +$1.17M |
|
|
OSB
2483
DELISTED
Norbord Inc.
OSB
| $1.51M | ﹤0.01% |
48,600
-70
| -0.1% | -$2.07K |
|
|
ARRS
2484
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $1.51M | ﹤0.01% |
53,856
-235,723
| -81% | -$6.48M |
|
2485
PUT
Travel + Leisure Co
TNL
$4.74B
| $1.51M | ﹤0.01% |
33,225
+29,681
| +838% | +$1.29M |
|
2486
CALL
Iron Mountain
IRM
$36.3B
| $1.5M | ﹤0.01% |
43,800
+42,800
| +4,280% | +$1.5M |
|
2487
CALL
Vipshop
VIPS
$7.4B
| $1.5M | ﹤0.01% |
142,700
+120,000
| +529% | +$1.57M |
|
2488
W.R. Berkley
WRB
$26.8B
| $1.5M | ﹤0.01% |
73,454
+3,591
| +5% | +$72.7K |
|
2489
MBIA
MBI
$269M
| $1.5M | ﹤0.01% |
159,502
-19,186
| -11% | -$163K |
|
2490
CALL
Crown Castle
CCI
$31.9B
| $1.5M | ﹤0.01% |
15,000
+5,400
| +56% | +$531K |
|
2491
PUT
Royal Gold
RGLD
$18.5B
| $1.5M | ﹤0.01% |
19,200
+2,800
| +17% | +$211K |
|
2492
PUT
MPLX
MPLX
$61.3B
| $1.5M | ﹤0.01% |
44,754
+38,200
| +583% | +$1.32M |
|
2493
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$228M
| $1.5M | ﹤0.01% |
3
+1
| +50% | +$657K |
|
2494
CALL
Travelers Companies
TRV
$80.5B
| $1.49M | ﹤0.01% |
11,800
+1,300
| +12% | +$160K |
|
2495
Alamo Group
ALG
$2.02B
| $1.49M | ﹤0.01% |
16,410
+890
| +6% | +$74.2K |
|
|
TEI
2496
Templeton Emerging Markets Income Fund
TEI
$318M
| $1.49M | ﹤0.01% |
132,832
| – | – |
|
|
DCP
2497
DELISTED
DCP Midstream, LP
DCP
| $1.49M | ﹤0.01% |
43,993
-239,507
| -84% | -$8.54M |
|
|
CAA
2498
CALL
DELISTED
CalAtlantic Group, Inc.
CAA
| $1.49M | ﹤0.01% |
42,100
+9,800
| +30% | +$356K |
|
|
TVRD
2499
Tvardi Therapeutics
TVRD
$23.1M
| $1.49M | ﹤0.01% |
2,680
+616
| +30% | +$391K |
|
2500
Apogee Enterprises
APOG
$900M
| $1.48M | ﹤0.01% |
26,123
-29,743
| -53% | -$1.63M |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.